Floatz logo

Zoladex

Breast Cancer - Female

H. Lee Moffitt Cancer Center and Research InstitutePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Breast Cancer - Female cohort.

Asset / SponsorPhaseRating
Arimidex
Ahon Pharmaceutical Co., Ltd.
Phase 4BBB
PROPOFOL
Tata Memorial Centre
Phase 4BB
Sevoflurane
Tata Memorial Centre
Phase 4BB
Zoladex
Ahon Pharmaceutical Co., Ltd.
Phase 3BB
Gtx-006
Peking Union Medical College Hospital
Phase 4BB

View all 22 →

Same molecule, other indications

Zoladex is also rated in:

HR+/HER2- Breast CancerDormant
BB
Indicative ·
71 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
prostate adenocarcinomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →